Meet Our Executive Team

Russ Riggs, MD

Tropocells USA Executive Director

Dr. Riggs has been using regenerative therapies in clinical practice for the past 6 years.  His clinic in Portland, Oregon was the first in the U.S. to use Tropocells PRP. 

“Tropocells is by far the best PRP kit on the U.S. market.  It does not produce a painful inflammatory flare like other systems since it removes 100% of the RBCs and >90% of the neutrophils.  Our patients have had very positive clinical outcomes with Tropocells.  Its ease of use, consistent formulation, and superior cellular profile make Tropocells the PRP system of choice.”

Ryan Riggs, MD

Tropocells USA Chief Medical Officer - PRP Division

Dr. Riggs is a specialist in regenerative orthobiologics. He has researched and sampled many PRP systems and is passionate about the Tropocells PRP system because of its unique  cell-separation technology and optimized formulation.

“No other system comes close to delivering such a strong anabolic profile. Tropocells PRP is an outstanding product. It’s competitively priced, easy to use, and it consistently provides quality clinical outcomes — thus making it exceptional for business, staff, and patients.” 

Contact Us

For more information, email us at info@tropocells.com

FDA cleared 510(k) Class II medical device: Tropocells PRP is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK110035

© 2018 All Rights Reserved to Estar Technologies Ltd.